News of the WeekIntellectual Property

DuPont Ups Ante on Use of Harvard's OncoMouse

See allHide authors and affiliations

Science  17 May 2002:
Vol. 296, Issue 5571, pp. 1212
DOI: 10.1126/science.296.5571.1212

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

DuPont is becoming more assertive about asking U.S. researchers to obtain licenses for permission to use the Harvard OncoMouse. The company--arguing that its OncoMouse patents cover any transgenic animal predisposed to cancer--is also asking institutions to enforce the agreements. Some have complied readily, according to DuPont, but others, including the Massachusetts Institute of Technology and the University of California, appear to be dragging their feet. And a few researchers and administrators are up in arms.